LifeMD operates a direct-to-patient telehealth platform that connects consumers with healthcare professionals for virtual medical services across the United States. The company's primary telehealth offerings include RexMD, which addresses men's health conditions such as erectile dysfunction and hair loss; ShapiroMD, focusing on hair loss treatment for both men and women; and Cleared, which provides allergy, asthma, and immunology care. The company also operates LifeMD PC, a virtual primary care service offering on-demand consultations, prescription medications, diagnostics, and wellness coaching.
Beyond telehealth, LifeMD operates a secondary segment called WorkSimpli, which encompasses several productivity and professional services software platforms. These include PDFSimpli for document management, ResumeBuild for resume and cover letter creation, SignSimpli for digital signatures, and LegalSimpli for legal form services. The company also offers GLP-1 medications for weight management and in-home health monitoring devices as part of its broader service portfolio.
LifeMD distributes its offerings through direct-to-consumer channels, e-commerce platforms, and third-party partnerships. The company maintains a relatively lean operational structure with approximately 304 full-time employees and is headquartered in New York, New York. LifeMD was incorporated in Delaware in 1994 and trades on the Nasdaq exchange.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | — | — | |
| 2023 | — | — | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | $-0.03 | $-0.03 | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-11 | 0001493152-25-009790 | SEC ↗ |
| 2023-12-31 | 2024-03-11 | 0001493152-24-009581 | SEC ↗ |
| 2022-12-31 | 2023-03-22 | 0001493152-23-008560 | SEC ↗ |
| 2021-12-31 | 2022-03-07 | 0001493152-22-006182 | SEC ↗ |
| 2020-12-31 | 2021-03-30 | 0001493152-21-007194 | SEC ↗ |
| 2019-12-31 | 2020-03-30 | 0001493152-20-005288 | SEC ↗ |
| 2018-12-31 | 2019-04-01 | 0001213900-19-005312 | SEC ↗ |
| 2017-12-31 | 2018-04-02 | 0001213900-18-003893 | SEC ↗ |
| 2016-12-31 | 2017-05-24 | 0001213900-17-005790 | SEC ↗ |
| 2015-12-31 | 2016-03-30 | 0001213900-16-011978 | SEC ↗ |
| 2014-12-31 | 2015-03-30 | 0001213900-15-002217 | SEC ↗ |
| 2013-12-31 | 2014-03-28 | 0001213900-14-001835 | SEC ↗ |
| 2012-12-31 | 2013-03-28 | 0001144204-13-018301 | SEC ↗ |